108 related articles for article (PubMed ID: 30720809)
1. Phenylboronic acid-functionalized polyamidoamine-mediated miR-34a delivery for the treatment of gastric cancer.
Song Z; Liang X; Wang Y; Han H; Yang J; Fang X; Li Q
Biomater Sci; 2019 Mar; 7(4):1632-1642. PubMed ID: 30720809
[TBL] [Abstract][Full Text] [Related]
2. Chondroitin sulfate-functionalized polyamidoamine as a tumor-targeted carrier for miR-34a delivery.
Chen W; Liu Y; Liang X; Huang Y; Li Q
Acta Biomater; 2017 Jul; 57():238-250. PubMed ID: 28511876
[TBL] [Abstract][Full Text] [Related]
3. Phenylboronic acid-functionalized polyamidoamine-mediated Bcl-2 siRNA delivery for inhibiting the cell proliferation.
Wu D; Yang J; Xing Z; Han H; Wang T; Zhang A; Yang Y; Li Q
Colloids Surf B Biointerfaces; 2016 Oct; 146():318-25. PubMed ID: 27371891
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of proliferation and migration of tumor cells through phenylboronic acid-functionalized polyamidoamine-mediated delivery of a therapeutic DNAzyme Dz13.
Yang J; Zhang J; Xing J; Shi Z; Han H; Li Q
Int J Nanomedicine; 2019; 14():6371-6385. PubMed ID: 31496692
[TBL] [Abstract][Full Text] [Related]
5. Lipoic Acid-Modified Oligoethyleneimine-Mediated miR-34a Delivery to Achieve the Anti-Tumor Efficacy.
Huang Y; Wang L; Chen Y; Han H; Li Q
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443415
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cell proliferation and migration by chondroitin sulfate-g-polyethylenimine-mediated miR-34a delivery.
Liang S; Duan Y; Xing Z; Han H; Zhang A; Li L; Yang Y; Li Q
Colloids Surf B Biointerfaces; 2015 Dec; 136():577-84. PubMed ID: 26454548
[TBL] [Abstract][Full Text] [Related]
7. Phenylboronic Acid-Modified Polyamidoamine Mediated the Transfection of Polo-Like Kinase-1 siRNA to Achieve an Anti-Tumor Efficacy.
Gong G; Tang X; Zhang J; Liang X; Yang J; Li Q
Int J Nanomedicine; 2021; 16():8037-8048. PubMed ID: 34934312
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
9. Luteolin Induces Apoptosis by Up-regulating miR-34a in Human Gastric Cancer Cells.
Wu H; Huang M; Liu Y; Shu Y; Liu P
Technol Cancer Res Treat; 2015 Dec; 14(6):747-55. PubMed ID: 24988056
[TBL] [Abstract][Full Text] [Related]
10. Nucleobase-modified polyamidoamine-mediated miR-23b delivery to inhibit the proliferation and migration of lung cancer.
Han H; Yang J; Wang Y; Chen W; Chen J; Yang Y; Li Q
Biomater Sci; 2017 Oct; 5(11):2268-2275. PubMed ID: 28976503
[TBL] [Abstract][Full Text] [Related]
11. Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression.
Shi S; Han L; Deng L; Zhang Y; Shen H; Gong T; Zhang Z; Sun X
J Control Release; 2014 Nov; 194():228-37. PubMed ID: 25220161
[TBL] [Abstract][Full Text] [Related]
12. Sevoflurane induction alleviates the progression of gastric cancer by upregulating the miR-34a/TGIF2 axis.
Chen H; Zhu XM; Luo ZL; Hu YJ; Cai XC; Gu QH
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11883-11890. PubMed ID: 33275259
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
Zhang Z; Kong Y; Yang W; Ma F; Zhang Y; Ji S; Ma EM; Liu H; Chen Y; Hua Y
Oncol Rep; 2016 Oct; 36(4):2391-7. PubMed ID: 27513895
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Targeting Anti-MicroRNA-155 Delivery Based on Biodegradable Poly(ester amine) and Hyaluronic Acid Shielding for Lung Cancer Therapy.
Yang Y; Jia Y; Xiao Y; Hao Y; Zhang L; Chen X; He J; Zhao Y; Qian Z
Chemphyschem; 2018 Aug; 19(16):2058-2069. PubMed ID: 29488305
[TBL] [Abstract][Full Text] [Related]
15. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
Gaur S; Wen Y; Song JH; Parikh NU; Mangala LS; Blessing AM; Ivan C; Wu SY; Varkaris A; Shi Y; Lopez-Berestein G; Frigo DE; Sood AK; Gallick GE
Oncotarget; 2015 Oct; 6(30):29161-77. PubMed ID: 26313360
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
17. miR-335 directly, while miR-34a indirectly modulate survivin expression and regulate growth, apoptosis, and invasion of gastric cancer cells.
Yang B; Huang J; Liu H; Guo W; Li G
Tumour Biol; 2016 Feb; 37(2):1771-9. PubMed ID: 26318298
[TBL] [Abstract][Full Text] [Related]
18. Phenylboronic acid-modified polyamidoamine-mediated delivery of short GC rich DNA for hepatocarcinoma gene therapy.
Yang J; Zhang J; Liu Y; Shi Z; Han H; Li Q
Biomater Sci; 2019 Aug; 7(8):3348-3358. PubMed ID: 31218303
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2.
Hu Y; Pu Q; Cui B; Lin J
Int J Clin Exp Pathol; 2015; 8(8):8921-8. PubMed ID: 26464633
[TBL] [Abstract][Full Text] [Related]
20. Tumor targeting using polyamidoamine dendrimer-cisplatin nanoparticles functionalized with diglycolamic acid and herceptin.
Kesavan A; Ilaiyaraja P; Sofi Beaula W; Veena Kumari V; Sugin Lal J; Arunkumar C; Anjana G; Srinivas S; Ramesh A; Rayala SK; Ponraju D; Venkatraman G
Eur J Pharm Biopharm; 2015 Oct; 96():255-63. PubMed ID: 26277659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
